| ■ 영문 제목 : ELISA Analyzers Market Size, Share & Trends Analysis Report By Type (Optical Filter Elisa Analyzer, Optical Grating ELISA Analyzers), By Mode, By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030
|
 | ■ 상품코드 : GRV23MR090
■ 조사/발행회사 : Grand View Research
■ 발행일 : 2023년 2월
■ 페이지수 : 180
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (납기:3일)
■ 조사대상 지역 : 세계
■ 산업 분야 : 산업기계
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1인 열람용) | USD5,950 ⇒환산￦8,330,000 | 견적의뢰/주문/질문 |
| Multi User (5인 열람용) | USD6,950 ⇒환산￦9,730,000 | 견적의뢰/주문/질문 |
| Global/corporate License (기업 열람용) | USD8,950 ⇒환산￦12,530,000 | 견적의뢰/구입/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 ELISA 분석기 시장 규모가 2023년부터 2030년 사이에 CAGR 3.7% 증가하여, 2030년에는 754.38백만달러에 달할 것으로 예측하고 있습니다. 본 조사 자료는 세계의 ELISA 분석기 시장을 조사대상으로 하여, 조사 방법 및 범위, 개요, 시장 변동/동향/범위, 종류별 (광학 필터식 ELISA 분석기, 광학 격자식 ELISA 분석기) 분석, 모드별 (자동, 반자동) 분석, 용도별 (면역학, 백신 개발, 약물 모니터링, 기타) 분석, 최종 용도별 (바이오 테크놀로지 기업, 제약 기업, 위탁 연구 기관, 진단 연구소) 분석, 지역별 (북미, 유럽, 아시아 태평양, 중남미, 중동, 아프리카) 분석, 경쟁 현황 등의 내용을 수록하고 있습니다. 덧붙여 본 리포트는 Thermo Fisher Scientific, Abcam, Bio -Rad Laboratories, Merck KGaA, F. Hoffmann -La Roche Ltd., Danaher Corporation, BioTech, Agilent Technologies, QIAGEN, PerkinElmer Inc. 등의 기업 정보가 포함되어 있습니다.
・조사 방법 및 범위
・개요
・시장 변동/동향/범위
・세계의 ELISA 분석기 시장 규모 : 종류별
- 광학 필터식 ELISA 분석기의 시장 규모
- 광학 격자식 ELISA 분석기의 시장 규모
・세계의 ELISA 분석기 시장 규모 : 모드별
- 자동 ELISA 분석기의 시장 규모
- 반자동 ELISA 분석기의 시장 규모
・세계의 ELISA 분석기 시장 규모 : 용도별
- 면역학에 사용되는 ELISA 분석기의 시장 규모
- 백신 개발에 사용되는 ELISA 분석기의 시장 규모
- 약물 모니터링에 사용되는 ELISA 분석기의 시장 규모
- 기타 용도에 사용되는 ELISA 분석기의 시장 규모
・세계의 ELISA 분석기 시장 규모 : 최종 용도별
- 바이오 테크놀로지 기업에서 사용되는 ELISA 분석기의 시장 규모
- 제약 기업에서 사용되는 ELISA 분석기의 시장 규모
- 위탁 연구 기관에서 사용되는 ELISA 분석기의 시장 규모
- 진단 연구소에서 사용되는 ELISA 분석기의 시장 규모
・세계의 ELISA 분석기 시장 규모 : 지역별
- 북미의 ELISA 분석기 시장 규모
- 유럽의 ELISA 분석기 시장 규모
- 아시아 태평양의 ELISA 분석기 시장 규모
- 중남미의 ELISA 분석기 시장 규모
- 중동 및 아프리카의 ELISA 분석기 시장 규모
・경쟁 현황 |
■ 보고서 개요ELISA Analyzers Market Growth & Trends
The global ELISA analyzer market size is expected to reach USD 754.38 million by 2030 expanding at a CAGR of 3.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness a lucrative growth rate during the forecast period due to its repeated use in detecting infectious diseases, autoimmune diseases, endocrinology, drug monitoring, cardiology, oncology, and allergy testing, among other applications. Moreover, the high adoption rate of immunoassays in research activities is further anticipated to drive growth.
ELISA (Enzyme-linked Immunosorbent Assay) is extensively utilized for high-throughput screening of antibodies or drugs. The ELISA analyzer is anticipated to witness healthy growth due to its extensive test portfolio using immunoassay techniques coupled with affordable prices. Furthermore, the changing trends & advancements in medical devices and extensive utilization of immunoassay tests in point-of-care in vitro diagnostics, cancer diagnosis, therapeutic drug level monitoring, & infectious disease testing are factors likely to be responsible for the high growth of this segment.
Continuous technological advancements and the introduction of new products have also contributed to the ELISA analyzers market growth. For instance, in December 2019, Eurofins Abraxis announced to introduce an automatic ELISA analyzer, which comprises a single plate analysis system. The product assists with data analysis and personalized settings to adapt to laboratory testing requirements. The global market is determined by factors such as increasing demand for effective tests to detect hormones, autoimmune diseases, tumor markers, and infectious diseases with the rising number of research institutes worldwide. However, ELISA can only be applied on liquid samples, which proves to be a limitation, hampering its growth over the forecast period.
The growing R&D activities in the areas of immunoassay testing & equipment shall offer abundant opportunities for ELISA analyzers application expansion. These key players are continuously undertaking strategic initiatives to increase their market dominance throughout the forecast period.
In 2022, North America was leading in terms of revenue, followed by the European region. The dominance of North America region is accredited to its well-established market that is motivated by the existence of technologically advanced healthcare infrastructure, the presence of strong market players, and the increasing per capita healthcare expenditure in the region. Moreover, the presence of a huge geriatric population, large cancer & diabetic population, and a well-developed healthcare sector has primarily led to this growth in the U.S.
ELISA Analyzers Market Report Highlights
• By type, optical grating analyzer is considered to be a relatively more mature segment than optical filter analyzer and held the largest ELISA analyzer market share in 2022, owing to the increasing number of pharmaceutical and biotechnology companies establishing in-house research stations for developing diagnostic tools
• By Mode, automated analyzers is expected to capture the largest share of the market in 2022. Owing to the increasing investment by governments and international bodies to technologically advance the workflow of clinical diagnostics
• By application, the immunology segment is anticipated to capture the majority of the market share owing to the increasing incidence of infectious diseases in emerging markets, which is contributing to the growth
• By end-user, CROs are anticipated to be the fastest-growing segment. This growth can be attributed to the increasing collaborations and strategic partnerships between corporations and CROs that can advance the process of therapeutic formation
• North America has a dominant regional position with 40.50% of the overall market share. The increasing incidence of chronic & infectious diseases is encouraging companies to enter the regional ELISA analyzers market
■ 보고서 목차Table of Contents
Chapter 1. Methodology And Scope
1.1. Information Procurement
1.2. Information or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Growing Burden of Chronic and Infection Diseases
3.4.2. Technological Advancements in Diagnostic Testing
3.4.3. Rising Demand for Portable and Automated ELISA Assays
3.5. Market Restraint Analysis
3.5.1. Lower detection limit
3.6. Penetration and Growth Prospect Mapping 2022
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.7.2. Porter’s Five Forces Analysis
3.8. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. ELISA Analyzers Market: Type Movement Analysis
4.2. Optical Filter ELISA Analyzers
4.2.1. ELISA Analyzers Market For Optical Filter Elisa Analyzers, 2018 – 2030 (USD Million)
4.3. Optical Grating ELISA Analyzers
4.3.1. ELISA Analyzers Market For Optical Grating ELISA Analyzers, 2018 – 2030 (USD Million)
Chapter 5. Mode Business Analysis
5.1. ELISA Analyzers Market: Mode Movement Analysis
5.2. Automated ELISA Analyzers
5.2.1. ELISA Analyzers Market For Automated ELISA Analyzers, 2018 – 2030 (USD Million)
5.3. Semi-Automated ELISA Analyzers
5.3.1. ELISA Analyzers Market For Semi-Automated ELISA Analyzers, 2018 – 2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. ELISA Analyzers Market: Application Movement Analysis
6.2. Immunology
6.2.1. ELISA Analyzers Market For Immunology, 2018 – 2030 (USD Million)
6.3. Vaccine development
6.3.1. ELISA Analyzers Market For Vaccine development, 2018 – 2030 (USD Million)
6.4. Drug Monitoring
6.4.1. ELISA Analyzers Market For Drug Monitoring, 2018 – 2030 (USD Million)
6.5. Others
6.5.1. ELISA Analyzers Market For Others, 2018 – 2030 (USD Million)
Chapter 7. End-User Business Analysis
7.1. ELISA Analyzers Market: End-user Movement Analysis
7.2. Biotechnology Companies
7.2.1. ELISA Analyzers Market For Biotechnology Companies, 2018 – 2030 (USD Million)
7.3. Pharmaceutical Companies
7.3.1. ELISA Analyzers Market For Hospitals and Clinics, 2018 – 2030 (USD Million)
7.4. Contract Research Organization
7.4.1. ELISA Analyzers Market For Contract Research Organization, 2018 – 2030 (USD Million)
7.5. Diagnostic Laboratories
7.5.1. ELISA Analyzers Market For Diagnostic Laboratories, 2018 – 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. ELISA Analyzers Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. SWOT Analysis
8.2.2. North America ELISA Analyzers Market, By Type, 2018 – 2030 (USD Million)
8.2.3. North America ELISA Analyzers Market, By Mode, 2018 – 2030 (USD Million)
8.2.4. North America ELISA Analyzers Market, By Application, 2018 – 2030 (USD Million)
8.2.5. North America ELISA Analyzers Market, By End-User, 2018 – 2030 (USD Million)
8.2.6. U.S.
8.2.6.1. Key Country Dynamics
8.2.6.2. Target Disease Prevalence
8.2.6.3. Competitive Scenario
8.2.6.4. Regulatory Framework
8.2.6.5. Reimbursement Scenario
8.2.6.6. U.S. ELISA Analyzers Market 2018 – 2030 (USD MILLION)
8.2.7. Canada
8.2.7.1. Key Country Dynamics
8.2.7.2. Target Disease Prevalence
8.2.7.3. Competitive Scenario
8.2.7.4. Regulatory Framework
8.2.7.5. Reimbursement Scenario
8.2.7.6. Canada ELISA Analyzers Market 2018 – 2030 (USD Million)
8.3. Europe
8.3.1. SWOT Analysis
8.3.2. Europe ELISA Analyzers Market, By Type, 2018 – 2030 (USD Million)
8.3.3. Europe ELISA Analyzers Market, By Mode, 2018 – 2030 (USD Million)
8.3.4. Europe ELISA Analyzers Market, By Application, 2018 – 2030 (USD Million)
8.3.5. Europe ELISA Analyzers Market, By End-User, 2018 – 2030 (USD Million)
8.3.6. Germany
8.3.6.1. Key Country Dynamics
8.3.6.2. Target Disease Prevalence
8.3.6.3. Competitive Scenario
8.3.6.4. Regulatory Framework
8.3.6.5. Reimbursement Scenario
8.3.6.6. Germany ELISA Analyzers Market 2018 – 2030 (USD Million)
8.3.7. U.K.
8.3.7.1. Key Country Dynamics
8.3.7.2. Target Disease Prevalence
8.3.7.3. Competitive Scenario
8.3.7.4. Regulatory Framework
8.3.7.5. Reimbursement Scenario
8.3.7.6. U.K. ELISA Analyzers Market 2018 – 2030 (USD Million)
8.3.8. France
8.3.8.1. Key Country Dynamics
8.3.8.2. Target Disease Prevalence
8.3.8.3. Competitive Scenario
8.3.8.4. Regulatory Framework
8.3.8.5. Reimbursement Scenario
8.3.8.6. France ELISA Analyzers Market 2018 – 2030 (USD Million)
8.3.9. Italy
8.3.9.1. Key Country Dynamics
8.3.9.2. Target Disease Prevalence
8.3.9.3. Competitive Scenario
8.3.9.4. Regulatory Framework
8.3.9.5. Reimbursement Scenario
8.3.9.6. Italy ELISA Analyzers Market 2018 – 2030 (USD Million)
8.3.10. Spain
8.3.10.1. Key Country Dynamics
8.3.10.2. Target Disease Prevalence
8.3.10.3. Competitive Scenario
8.3.10.4. Regulatory Framework
8.3.10.5. Reimbursement Scenario
8.3.10.6. Spain ELISA Analyzers Market 2018 – 2030 (USD Million)
8.3.11. Denmark
8.3.11.1. Key Country Dynamics
8.3.11.2. Target Disease Prevalence
8.3.11.3. Competitive Scenario
8.3.11.4. Regulatory Framework
8.3.11.5. Reimbursement Scenario
8.3.11.6. Denmark ELISA Analyzers Market 2018 – 2030 (USD Million)
8.3.12. Sweden
8.3.12.1. Key Country Dynamics
8.3.12.2. Target Disease Prevalence
8.3.12.3. Competitive Scenario
8.3.12.4. Regulatory Framework
8.3.12.5. Reimbursement Scenario
8.3.12.6. Sweden ELISA Analyzers Market 2018 – 2030 (USD Million)
8.3.13. Norway
8.3.13.1. Key Country Dynamics
8.3.13.2. Target Disease Prevalence
8.3.13.3. Competitive Scenario
8.3.13.4. Regulatory Framework
8.3.13.5. Reimbursement Scenario
8.3.13.6. Norway ELISA Analyzers Market 2018 – 2030 (USD Million)
8.4. Asia Pacific
8.4.1. SWOT Analysis
8.4.2. Asia Pacific ELISA Analyzers Market, By Type, 2018 – 2030 (USD Million)
8.4.3. Asia Pacific ELISA Analyzers Market, By Mode, 2018 – 2030 (USD Million)
8.4.4. Asia Pacific ELISA Analyzers Market, By Application, 2018 – 2030 (USD Million)
8.4.5. Asia Pacific ELISA Analyzers Market, By End-User, 2018 – 2030 (USD Million)
8.4.6. Japan
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Regulatory Framework
8.4.6.5. Reimbursement Scenario
8.4.6.6. Japan ELISA Analyzers Market 2018 – 2030 (USD Million)
8.4.7. China
8.4.7.1. Key Country Dynamics
8.4.7.2. Target Disease Prevalence
8.4.7.3. Competitive Scenario
8.4.7.4. Regulatory Framework
8.4.7.5. Reimbursement Scenario
8.4.7.6. China ELISA Analyzers Market 2018 – 2030 (USD Million)
8.4.8. India
8.4.8.1. Key Country Dynamics
8.4.8.2. Target Disease Prevalence
8.4.8.3. Competitive Scenario
8.4.8.4. Regulatory Framework
8.4.8.5. Reimbursement Scenario
8.4.8.6. India ELISA Analyzers Market 2018 – 2030 (USD Million)
8.4.9. South Korea
8.4.9.1. Key Country Dynamics
8.4.9.2. Target Disease Prevalence
8.4.9.3. Competitive Scenario
8.4.9.4. Regulatory Framework
8.4.9.5. Reimbursement Scenario
8.4.9.6. South Korea ELISA Analyzers Market 2018 – 2030 (USD Million)
8.4.10. Australia
8.4.10.1. Key Country Dynamics
8.4.10.2. Target Disease Prevalence
8.4.10.3. Competitive Scenario
8.4.10.4. Regulatory Framework
8.4.10.5. Reimbursement Scenario
8.4.10.6. Australia ELISA Analyzers Market 2018 – 2030 (USD Million)
8.4.11. Thailand
8.4.11.1. Key Country Dynamics
8.4.11.2. Target Disease Prevalence
8.4.11.3. Competitive Scenario
8.4.11.4. Regulatory Framework
8.4.11.5. Reimbursement Scenario
8.4.11.6. Thailand ELISA Analyzers Market 2018 – 2030 (USD Million)
8.5. Latin America
8.5.1. SWOT Analysis
8.5.2. Latin America ELISA Analyzers Market, By Type, 2018 – 2030 (USD Million)
8.5.3. Latin America ELISA Analyzers Market, By Mode, 2018 – 2030 (USD Million)
8.5.4. Latin America ELISA Analyzers Market, By Application, 2018 – 2030 (USD Million)
8.5.5. Latin America ELISA Analyzers Market, By End-User, 2018 – 2030 (USD Million)
8.5.6. Brazil
8.5.6.1. Key Country Dynamics
8.5.6.2. Target Disease Prevalence
8.5.6.3. Competitive Scenario
8.5.6.4. Regulatory Framework
8.5.6.5. Reimbursement Scenario
8.5.6.6. Brazil ELISA Analyzers Market 2018 – 2030 (USD Million)
8.5.7. Mexico
8.5.7.1. Key Country Dynamics
8.5.7.2. Target Disease Prevalence
8.5.7.3. Competitive Scenario
8.5.7.4. Regulatory Framework
8.5.7.5. Reimbursement Scenario
8.5.7.6. Mexico ELISA Analyzers Market 2018 – 2030 (USD Million)
8.5.8. Argentina
8.5.8.1. Key Country Dynamics
8.5.8.2. Target Disease Prevalence
8.5.8.3. Competitive Scenario
8.5.8.4. Regulatory Framework
8.5.8.5. Reimbursement Scenario
8.5.8.6. Argentina ELISA Analyzers Market 2018 – 2030 (USD Million)
8.6. MEA
8.6.1. SWOT Analysis
8.6.2. MEA ELISA Analyzers Market, By Type, 2018 – 2030 (USD Million)
8.6.3. MEA ELISA Analyzers Market, By Mode, 2018 – 2030 (USD Million)
8.6.4. MEA ELISA Analyzers Market, By Application, 2018 – 2030 (USD Million)
8.6.5. MEA ELISA Analyzers Market, By End-User, 2018 – 2030 (USD Million)
8.6.6. South Africa
8.6.6.1. Key Country Dynamics
8.6.6.2. Target Disease Prevalence
8.6.6.3. Competitive Scenario
8.6.6.4. Regulatory Framework
8.6.6.5. Reimbursement Scenario
8.6.6.6. South Africa ELISA Analyzers Market 2018 – 2030 (USD Million)
8.6.7. Saudi Arabia
8.6.7.1. Key Country Dynamics
8.6.7.2. Target Disease Prevalence
8.6.7.3. Competitive Scenario
8.6.7.4. Regulatory Framework
8.6.7.5. Reimbursement Scenario
8.6.7.6. Saudi Arabia ELISA Analyzers Market 2018 – 2030 (USD Million)
8.6.8. UAE
8.6.8.1. Key Country Dynamics
8.6.8.2. Target Disease Prevalence
8.6.8.3. Competitive Scenario
8.6.8.4. Regulatory Framework
8.6.8.5. Reimbursement Scenario
8.6.8.6. UAE ELISA Analyzers Market 2018 – 2030 (USD Million)
8.6.9. Kuwait
8.6.9.1. Key Country Dynamics
8.6.9.2. Target Disease Prevalence
8.6.9.3. Competitive Scenario
8.6.9.4. Regulatory Framework
8.6.9.5. Reimbursement Scenario
8.6.9.6. Kuwait ELISA Analyzers Market 2018 – 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant’s overview
9.2. Financial performance
9.3. Participant categorization
9.3.1. Market Leaders
9.3.2. ELISA Analyzers Market Share Analysis, 2022
9.3.3. Company Profiles
9.3.3.1. Thermo Fisher Scientific
9.3.3.2. Abcam
9.3.3.3. Bio-Rad Laboratories
9.3.3.4. Merck KGaA
9.3.3.5. F. Hoffmann-La Roche Ltd.
9.3.3.6. Danaher Corporation
9.3.3.7. BioTech
9.3.3.8. Agilent Technologies
9.3.3.9. QIAGEN
9.3.3.10. PerkinElmer Inc.
9.3.4. Strategy Mapping
9.3.4.1. Expansion
9.3.4.2. Acquisition
9.3.4.3. Collaborations
9.3.4.4. Product/Service Launch
9.3.4.5. Partnerships
9.3.4.6. Others
|
| ※본 조사보고서 [세계의 ELISA 분석기 시장 (2023~2030) : 광학 필터식 ELISA 분석기, 광학 격자식 ELISA 분석기] (코드 : GRV23MR090) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 ELISA 분석기 시장 (2023~2030) : 광학 필터식 ELISA 분석기, 광학 격자식 ELISA 분석기] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요! 세계의 ELISA 분석기 시장 (2023~2030) : 광학 필터식 ELISA 분석기, 광…
